Literature DB >> 32329645

Traditional Chinese Medicine for Alzheimer's Disease and Other Cognitive Impairment: A Review.

Hui Pei1, Lina Ma1, Yu Cao1, Feixue Wang2, Zehui Li1, Nanyang Liu1, Meixia Liu1, Yun Wei1, Hao Li1.   

Abstract

Cognitive impairment (CI) refers to the dysfunction of memory, language, visual space, execution, calculation, understanding, and judgment in one or more aspects. With global aging, CI will become prevalent worldwide. At present, there is no effective cure for CI. However, Nobel laureate Tu Youyou's research on artemisinin has inspired Chinese researchers to focus on traditional Chinese herbs (TCHs) for the treatment of CI. Traditional Chinese Medicine (TCM) has led to a theory for an independent CI system. The pathogenesis of such impairment involves deficiency, phlegm, and stagnation and involves a range of organs, including the brain, kidneys, heart, liver, and spleen. Our current understanding of the etiology and pathogenesis of this condition has led to the realization that TCHs can improve cognitive dysfunction. Clinical research has shown that TCHs can improve the neuropsychological scale score of patients, the TCM symptom score, and the patient's quality of life. Research has also suggested that TCHs can retard Aβ deposits and tauopathy, regulate the metabolism of cholinergic neurotransmitters, and so on. However, due to their complexity, little is known of the safety and efficacy of TCHs in patients with CI. It is likely that we will be able to identify the precise mechanisms associated with the action of TCHs in such patients due to the integration of multiple technologies. This paper summarizes the pharmacokinetics, curative effect, and mechanisms of action of traditional Chinese herbs in order to provide a scientific basis for the improvement of cognitive dysfunction by TCHs.

Entities:  

Keywords:  Action Mechanism; Cognitive Impairment; Pharmacokinetics; Review; Traditional Chinese Herbs

Mesh:

Substances:

Year:  2020        PMID: 32329645     DOI: 10.1142/S0192415X20500251

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  18 in total

1.  Effects and Mechanisms of Synaptotagmin-7 in the Hippocampus on Cognitive Impairment in Aging Mice.

Authors:  Yaru Xie; Kaining Zhi; Xianfang Meng
Journal:  Mol Neurobiol       Date:  2021-08-17       Impact factor: 5.590

2.  The Association Between Cognitive Impairment and Subsequent Falls Among Older Adults: Evidence From the China Health and Retirement Longitudinal Study.

Authors:  Rong Zhou; Jiayu Li; Meiling Chen
Journal:  Front Public Health       Date:  2022-06-15

Review 3.  Traditional Chinese Medicine as a Promising Strategy for the Treatment of Alzheimer's Disease Complicated With Osteoporosis.

Authors:  Weifan Xu; Yiping Jiang; Nani Wang; Huanhuan Bai; Shengyan Xu; Tianshuang Xia; Hailiang Xin
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

4.  Based on Network Pharmacology and Molecular Dynamics Simulations, Baicalein, an Active Ingredient of Yiqi Qingre Ziyin Method, Potentially Protects Patients With Atrophic Rhinitis From Cognitive Impairment.

Authors:  Xueran Kang; Yuxing Sun; Bin Yi; Chenyan Jiang; Xiaojun Yan; Bin Chen; Lixing Lu; Fangze Shi; Yuanbo Luo; Yisheng Chen; Qian Wang; Runjie Shi
Journal:  Front Aging Neurosci       Date:  2022-06-10       Impact factor: 5.702

Review 5.  Transcranial Direct Current Stimulation Enhances Cognitive Function in Patients with Mild Cognitive Impairment and Early/Mid Alzheimer's Disease: A Systematic Review and Meta-Analysis.

Authors:  Jiajie Chen; Zheng Wang; Qin Chen; Yu Fu; Kai Zheng
Journal:  Brain Sci       Date:  2022-04-27

Review 6.  Current Progress on Neuroprotection Induced by Artemisia, Ginseng, Astragalus, and Ginkgo Traditional Chinese Medicines for the Therapy of Alzheimer's Disease.

Authors:  Qin Li; Limor Rubin; Marta Silva; Shuai Li; Chao Yang; Philip Lazarovici; Wenhua Zheng
Journal:  Oxid Med Cell Longev       Date:  2022-06-14       Impact factor: 7.310

7.  Explore the Therapeutic Composition and Mechanism of Schisandra chinensis-Acorus tatarinowii Schott on Alzheimer's Disease by Using an Integrated Approach on Chemical Profile, Network Pharmacology, and UPLC-QTOF/MS-Based Metabolomics Analysis.

Authors:  Jian Chen; WenQian Hao; Chengqin Zhang; MeiRong Cui; Yue Sun; Ying Zhang; Jing Wang; TingTing Mou; Shuo Gu; TianTian Zhao; Binbin Wei
Journal:  Oxid Med Cell Longev       Date:  2022-07-11       Impact factor: 7.310

Review 8.  Redox signaling and Alzheimer's disease: from pathomechanism insights to biomarker discovery and therapy strategy.

Authors:  Yuan-Yuan Chen; Min-Chang Wang; Yan-Ni Wang; He-He Hu; Qing-Quan Liu; Hai-Jing Liu; Ying-Yong Zhao
Journal:  Biomark Res       Date:  2020-09-11

9.  Bu Shen Yi Sui Capsule Alleviates Neuroinflammation and Demyelination by Promoting Microglia toward M2 Polarization, Which Correlates with Changes in miR-124 and miR-155 in Experimental Autoimmune Encephalomyelitis.

Authors:  Zheng Zha; Yan-Fang Gao; Jing Ji; Ya-Qin Sun; Jun-Ling Li; Fang Qi; Nan Zhang; Liang-Yun Jin; Bing Xue; Tao Yang; Yong-Ping Fan; Hui Zhao; Lei Wang
Journal:  Oxid Med Cell Longev       Date:  2021-03-16       Impact factor: 6.543

10.  A network pharmacology approach to uncover the key ingredients in Ginkgo Folium and their anti-Alzheimer's disease mechanisms.

Authors:  Peng Zeng; Meng Fang; Han Zhao; Jing Guo
Journal:  Aging (Albany NY)       Date:  2021-07-27       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.